Free Trial

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Consensus Rating of "Buy" by Brokerages

Reckitt Benckiser Group logo with Consumer Staples background

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have been given an average rating of "Buy" by the eight analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and four have assigned a strong buy rating to the company.

Separately, Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th.

Read Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Up 0.5%

RBGLY stock opened at $13.55 on Friday. The company has a current ratio of 0.58, a quick ratio of 0.39 and a debt-to-equity ratio of 1.08. The firm has a 50-day moving average of $13.61 and a two-hundred day moving average of $13.21. Reckitt Benckiser Group has a 12 month low of $10.43 and a 12 month high of $14.15.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines